Form 4 Tracker
James R. Kasinger

General Counsel and Secretary · 8 filings · Latest: Oct 13, 2026

CRISPR Therapeutics AG
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
CRSP
James R. KasingerGeneral Counsel and SecretaryOct 14, 2026
Sale
$49.261,040$51.2K95,857
CRSP
James R. KasingerGeneral Counsel and SecretaryOct 13, 2026
Option Exercise
—2,113—96,897
CRSP
James R. KasingerGeneral Counsel and SecretaryOct 6, 2026
Sale
$60.041,990$119.5K94,784
CRSP
James R. KasingerGeneral Counsel and SecretaryOct 6, 2026
Option Exercise
$13.621,990$27.1K96,774
CRSP
JAMES KASINGER—Oct 6, 2026
Proposed Sale
$60.041,990$119.5K—
CRSP
James R. KasingerGeneral Counsel and SecretarySep 22, 2026
Sale
$60.2410,400$626.5K94,784
CRSP
James R. KasingerGeneral Counsel and SecretarySep 22, 2026
Option Exercise
$13.6210,400$141.6K105,184
CRSP
JAMES KASINGER—Sep 22, 2026
Proposed Sale
$60.2410,400$626.5K—
CRSP
James R. KasingerGeneral Counsel and SecretaryMar 23, 2026
Sale
$46.783,182$148.9K94,308
CRSP
James R. KasingerGeneral Counsel and SecretaryMar 20, 2026
Option Exercise
—6,250—97,490
CRSP
James R. KasingerGeneral Counsel and SecretaryMar 16, 2026
Sale
$48.263,450$166.5K91,240
CRSP
James R. KasingerGeneral Counsel and SecretaryMar 14, 2026
Option Exercise
—6,875—94,690
CRSP
James R. KasingerGeneral Counsel and SecretaryMar 11, 2026
Sale
$52.802,800$147.8K87,815
CRSP
James R. KasingerGeneral Counsel and SecretaryMar 10, 2026
Option Exercise
—5,500—90,615
CRSP
James R. KasingerGeneral Counsel and SecretaryFeb 19, 2026
Sale
$52.582,112$111.0K85,115
CRSP
James R. KasingerGeneral Counsel and SecretaryFeb 18, 2026
Option Exercise
—3,825—87,227